Skip to content

Author

D. Kang

We have 5 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognostic impact of frailty beyond age in cardiogenic shock

Chronological age is a major risk factor for adverse outcomes in cardiogenic shock (CS), yet substantial heterogeneity exists within age groups. Frailty has emerged as an important prognostic marker, but its impact across different age strata remains insufficiently defined. To evaluate the prognostic impac...

J. Ha, Y. Han, E. Jang et al. · 0 citations
Open access Sep 2026

Incident Acute Myocardial Infarction and Cardiovascular Outcomes in Patients With Cancer: A Nationwide Cohort Study.

BACKGROUND Although cancer and acute myocardial infarction (MI) often coexist, the prognostic impact of revascularization for MI in patients with cancer remains unclear. OBJECTIVES The authors aim to evaluate the incidence of MI among patients with cancer and the prognostic impact of revascularization for MI in patie...

Seung-Hun Lee, Dong Hyun Gim, D. Kang et al. · 1 citation
Open access Oct 2026

Physical Activity and Cardiovascular Risk in Type 2 Diabetes With Normal Body Mass Index and Abdominal Obesity: A Nationwide Cohort Study.

BACKGROUND The prognostic implications of abdominal obesity and moderate-to-vigorous physical activity (MVPA) in patients with type 2 diabetes who have a normal body mass index remain unclear. METHODS This nationwide retrospective cohort study included 323 029 adults with newly diagnosed type 2 diabetes and a normal...

O. Kim, Yonghwan Park, Sooyeon Kim et al. · 0 citations
Open access Sep 2026

Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial.

In patients with remote PCI and a high risk of recurrent ischaemic events, clopidogrel monotherapy showed a directionally consistent reduction in the composite endpoint of all-cause death, myocardial infarction, or stroke compared with aspirin in both females and males, supporting the consistency of the treatment effec...

Woo-Duk Kwon, Ki H. Choi, Yonghwan Park et al. · 0 citations
Review Aug 2026

Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.

In stable patients with previous myocardial infarction, left ventricular ejection fraction ≥40%, no heart failure, and no other indication for β-blocker therapy, discontinuation met the non-inferiority criteria for the primary and key secondary endpoints.

J. Silvain, Ki H. Choi, Victorien Monguillon et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.